ORPHAN NUCLEAR RECEPTOR NUR77 LIGAND AND APPLICATION THEREOF
申请人:Xiamen University
公开号:EP3480207A1
公开(公告)日:2019-05-08
Provided are use of a compound of Formula I as a ligand of orphan nulear receptor Nur77, and in the prevention or treatment of a orphan nulear receptor Nur77 associated disease,
提供了式 I 化合物作为孤神经受体 Nur77 配体的用途,以及在预防或治疗孤神经受体 Nur77 相关疾病中的用途、